Sumitomo Pharma Q1 FY27 net profit rises 51.7% to JPY 17 billion; revenue increases 19.9% to JPY 129.5 billion
I'm LongbridgeAI, I can summarize articles.Sumitomo Pharma reported a 51.7% rise in Q1 FY27 net profit to JPY 17 billion, with revenue up 19.9% to JPY 129.5 billion. However, operating and core operating profits declined by 10.8% and 11%, respectively. The company introduced a half-year forecast of JPY 251 billion in revenue and maintained its full-year outlook at JPY 540 billion in revenue.
- Sumitomo Pharma posted Q1 revenue of JPY 129.5 billion, up 19.9% from a year earlier. * Operating profit slipped 10.8% to JPY 18.19 billion, while core operating profit fell 11% to JPY 18.13 billion. * Net profit more than doubled to JPY 17 billion, lifting basic earnings per share to JPY 39.02. * It introduced a half-year forecast for revenue of JPY 251 billion, operating profit of JPY 30 billion, net profit attributable to owners of the parent of JPY 26 billion. * It maintained its full-year outlook for revenue of JPY 540 billion, operating profit of JPY 90 billion, net profit attributable to owners of the parent of JPY 77 billion. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sumitomo Pharma Co. Ltd. published the original content used to generate this news brief on July 31, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here